Wongtanasarasin Wachira, Srisurapanont Karan, Nishijima Daniel K
Department of Emergency Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Department of Emergency Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
J Clin Med. 2023 Jan 6;12(2):481. doi: 10.3390/jcm12020481.
Current guidelines for treating cardiac arrest recommend administering 1 mg of epinephrine every 3−5 min. However, this interval is based solely on expert opinion. We aimed to investigate the impact of the epinephrine administration interval (EAI) on resuscitation outcomes in adults with cardiac arrest. We systematically reviewed the PubMed, EMBASE, and Scopus databases. We included studies comparing different EAIs in adult cardiac arrest patients with reported neurological outcomes. Pooled estimates were calculated using the IVhet meta-analysis, and the heterogeneities were assessed using Q and I2 statistics. We evaluated the study risk of bias and overall quality using validated bias assessment tools. Three studies were included. All were classified as “good quality” studies. Only two reported the primary outcome. Compared with a recommended EAI of 3−5 min, a favorable neurological outcome was not significantly different in patients with the other frequencies: for <3 min, odds ratio (OR) 1.93 (95% CI: 0.82−4.54); for >5 min, OR 1.01 (95% CI: 0.55−1.87). For survival to hospital discharge, administering epinephrine for less than 3 min was not associated with a good outcome (OR 1.66, 95% CI: 0.89−3.10). Moreover, EAI of >5 min did not pose a benefit (OR 0.87, 95% CI: 0.68−1.11). Our review showed that EAI during CPR was not associated with better hospital outcomes. Further clinical trials are necessary to determine the optimal dosing interval for epinephrine in adults with cardiac arrest.
当前心脏骤停治疗指南建议每3 - 5分钟给予1毫克肾上腺素。然而,这一间隔时间完全基于专家意见。我们旨在研究肾上腺素给药间隔(EAI)对成年心脏骤停患者复苏结局的影响。我们系统检索了PubMed、EMBASE和Scopus数据库。我们纳入了比较成年心脏骤停患者不同EAI并报告神经学结局的研究。使用IVhet荟萃分析计算合并估计值,并使用Q和I²统计量评估异质性。我们使用经过验证的偏倚评估工具评估研究的偏倚风险和整体质量。纳入了三项研究。所有研究均被归类为“高质量”研究。只有两项研究报告了主要结局。与推荐的3 - 5分钟EAI相比,其他给药频率的患者神经学良好结局无显著差异:给药间隔<3分钟,比值比(OR)为1.93(95%置信区间:0.82 - 4.54);给药间隔>5分钟,OR为1.01(95%置信区间:0.55 - 1.87)。对于出院存活情况,肾上腺素给药时间少于3分钟与良好结局无关(OR为1.66,95%置信区间:0.89 - 3.10)。此外,给药间隔>5分钟也未显示出益处(OR为0.87,95%置信区间:0.68 - 1.11)。我们的综述表明,心肺复苏期间的EAI与更好的医院结局无关。有必要进行进一步的临床试验来确定成年心脏骤停患者肾上腺素的最佳给药间隔。